Literature DB >> 27976508

Obesity, weight change, and chronic kidney disease in patients with type 2 diabetes mellitus: A longitudinal study in Taiwan.

Hsin-Fang Chung1, Abdullah Al Mamun1, Meng-Chuan Huang2,3, Kurt Z Long1,4, Ya-Fang Huang5, Shyi-Jang Shin6, Shang-Jyh Hwang7, Chih-Cheng Hsu5,8,9.   

Abstract

BACKGROUND: The aim of the present study was to investigate relationships between the risk of chronic kidney disease (CKD) and obesity and weight changes in Asian patients with type 2 diabetes.
METHODS: At baseline (2003-05), 1187 diabetic patients aged 30-70 years were recruited to the study, with follow-up surveys completed in 2008, 2009, and 2010. Chronic kidney disease was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min per 1.73 m2 ; body mass index (BMI) was categorised as normal (18.5-22.9 kg/m2 ), overweight (23-27.4 kg/m2 ), or obese (≥27.5 kg/m2 ); waist circumference (WC) ≥80 cm for women and ≥90 cm for men was taken to indicate abdominal obesity. Changes in weight and WC were calculated from baseline to each follow-up survey. Relative risk (RR) and 95% confidence intervals (CIs) of CKD were estimated. To estimate the risk for incident CKD, associations were examined in patients without CKD at baseline (n = 881).
RESULTS: Over 7 years of follow-up, obesity (RR 1.48; 95% CI 1.08-2.04; P = 0.015) and high WC (RR 1.23; 95% CI 1.00-1.52; P = 0.049) were associated with CKD after adjusting for covariates. Among participants without CKD at baseline, those who gained >10% weight (RR 1.43; 95% CI 1.07-1.90; P = 0.015) and in whom WC increased >15% (RR 1.37; 95% CI 1.01-1.85; P = 0.045) had a higher risk of incident CKD than those who remained stable (±5% changes in weight or WC).
CONCLUSIONS: Diabetic patients who are obese and those with excessive central fat were more likely to have CKD. Large weight gain (>10%) and increases in WC (>15%) independently predicted incident CKD.
© 2016 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  2型糖尿病; Asian; chronic kidney disease; obesity; type 2 diabetes; weight change; 亚洲人; 体重改变; 慢性肾病; 肥胖

Mesh:

Year:  2017        PMID: 27976508     DOI: 10.1111/1753-0407.12514

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  12 in total

1.  Antizyme inhibitor 1 genetic polymorphisms associated with diabetic patients validated in the livers of diabetic mice.

Authors:  Cheng-Hsu Chen; Yeh-Han Wang; Shang-Feng Tsai; Tung-Min Yu; Shih-Yin Chen; Fuu-Jen Tsai
Journal:  Exp Ther Med       Date:  2019-08-20       Impact factor: 2.447

2.  The risk of consequent nephropathy following initial weight loss in diabetic patients treated with sodium glucose cotransporter 2 inhibitors.

Authors:  Yi-Hsin Chan; Shao-Wei Chen; Tze-Fan Chao; Yi-Wei Kao; Chien-Ying Huang; Pao-Hsien Chu
Journal:  Cardiovasc Diabetol       Date:  2021-08-16       Impact factor: 9.951

3.  Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey.

Authors:  Jiayu Duan; Chongjian Wang; Dongwei Liu; Yingjin Qiao; Shaokang Pan; Dengke Jiang; Zihao Zhao; Lulu Liang; Fei Tian; Pei Yu; Yu Zhang; Huanhuan Zhao; Zhangsuo Liu
Journal:  Sci Rep       Date:  2019-07-18       Impact factor: 4.379

4.  BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.

Authors:  Elli Polemiti; Julia Baudry; Olga Kuxhaus; Susanne Jäger; Manuela M Bergmann; Cornelia Weikert; Matthias B Schulze
Journal:  Diabetologia       Date:  2021-01-15       Impact factor: 10.122

5.  Association between obesity and urinary albumin-creatinine ratio in the middle-aged and elderly population of Southern and Northern China: a cross-sectional study.

Authors:  Shan Qin; Anping Wang; Shi Gu; Weiqing Wang; Zhengnan Gao; Xulei Tang; Li Yan; Qin Wan; Zuojie Luo; Guijun Qin; Lulu Chen; Guang Ning; Yiming Mu
Journal:  BMJ Open       Date:  2021-01-05       Impact factor: 2.692

6.  The Predictive Value of Visceral Adiposity Index and Lipid Accumulation Index for Microalbuminuria in Newly Diagnosed Type 2 Diabetes Patients.

Authors:  Licui Qi; Ning Kang; Yong Li; Hang Zhao; Shuchun Chen
Journal:  Diabetes Metab Syndr Obes       Date:  2021-03-11       Impact factor: 3.168

7.  Anthropometric Measures and Incident Diabetic Nephropathy in Participants With Type 2 Diabetes Mellitus.

Authors:  Daniel Nyarko Hukportie; Fu-Rong Li; Rui Zhou; Jia-Zhen Zheng; Xiao-Xiang Wu; Xian-Bo Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-04       Impact factor: 5.555

8.  Association of Predicted Lean Body Mass and Fat Mass With Incident Diabetic Nephropathy in Participants With Type 2 Diabetes Mellitus: A Post Hoc Analysis of ACCORD Trial.

Authors:  Daniel Nyarko Hukportie; Fu-Rong Li; Rui Zhou; Meng-Chen Zou; Xiao-Xiang Wu; Xian-Bo Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-27       Impact factor: 5.555

9.  Visceral adiposity and renal function: an observational study from SPECT-China.

Authors:  Kun Zhang; Qin Li; Yi Chen; Ningjian Wang; Yingli Lu
Journal:  Lipids Health Dis       Date:  2017-10-27       Impact factor: 3.876

Review 10.  Epidemiological characteristics of diabetic kidney disease in Taiwan.

Authors:  Jun-Sing Wang; Fu-Shun Yen; Kun-Der Lin; Shyi-Jang Shin; Yueh-Han Hsu; Chih-Cheng Hsu
Journal:  J Diabetes Investig       Date:  2021-10-03       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.